Ergomed plc: Revenue and EBITDA for full year 2019 expected to be ahead of market expectations

Ergomed plc: Appointments of Rolf Soderstrom and Dr Jim Esinhart as Non-Executive Directors

InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for IFX-1 in Hidradenitis Suppurativa

Adocia Presents First Half 2019 Financial Results

Atriva Therapeutics Receives EU Award for Biomarker Validation

Motif Bio plc: Motif Bio Submits Meeting Request and Package to the U.S. FDA for Iclaprim

ABIVAX Completes €12 Million Capital Raise Entirely Subscribed by Sofinnova Partners at Market Price

Heidelberg Pharma reports on first half-year

Newron’s commercialization partner Zambon and Valeo Pharma announce the launch of Onstryv® (safinamide) for Parkinson’s disease in Canada

Expedeon AG announces Outcome of Annual General Meeting 2019